UV-A Protection of Venara ANN-2526-1489/1

An In-Vivo study to Determine the UV-A Protection Factor of Venara ANN-2526-1489/1 - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2026/02/102655

Enrollment

Registered

2026-02-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product:Venara ANN-2526-1489/1: Quantity 2 mg/sq.cm Route of administration: Topical Frequency: Once Duration: 24 hour Control Intervention1: Not Applicable: Not Applicable

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age 18-70 years 2.Subjects with ITA value in the range of 20-41 . 3.Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator. 4.Individuals who have completed a preliminary medical history evaluation. 5.Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing. 6.Individuals with no known abnormal response to sunlight

Exclusion criteria

Exclusion criteria: 1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results. 2.Individuals with chronic skin allergies. 3.Individuals with suntan or sunburn. 4.Individuals with abnormal reaction to the sun. 5.Pregnant or lactating females. 6.Subjects accustomed to using sun beds. 7.Subjects who have participated in an UVAPF study within the last two months

Design outcomes

Primary

Measure	Time frame
Change in Individual MED (iMED) scoreTimepoint: Day 1,Day 2,Day 3	—

Secondary

Measure	Time frame
Not ApplicableTimepoint: Not Applicable	—

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results